Sempra Beats EPS Estimates at $1.40 as Revenue Falls Short at $3.19 Billion
Sempra updated its full-year 2026 GAAP EPS guidance to $7.41 to $8.41 and is guiding to the high end of its $4.80 to $5.30 adjusted range.
Stock reaction: SRE shares were down 2.8% at 11:10 a.m. ET on Nov. 5, from Nov. 4's close of $82.90. The S&P 500 was down 3.2% over the same span.

Key points
- Adjusted EPS of $1.40 beat the $1.21 consensus estimate; GAAP EPS was $1.34
- Revenue of $3.19 billion missed the $3.31 billion analyst estimate, up about 1% from a year earlier
- Full-year 2026 GAAP EPS guidance updated to $7.41 to $8.41; adjusted range $4.80 to $5.30, guiding to high end
- Oncor projects its 2027-2031 base capital plan to rise about 20%
Sempra (NYSE: SRE) reported third-quarter revenue of $3.19 billion, below the $3.31 billion analysts expected, and adjusted EPS of $1.40, above the $1.21 consensus estimate, in an 8-K filed Thursday, Nov. 5. Revenue rose about 1% from $3.15 billion a year earlier.
GAAP earnings were $877 million, or $1.34 per diluted share, compared with $77 million, or $0.12, in the third quarter of 2025. Adjusted earnings were $917 million, or $1.40 a share, against $728 million, or $1.11, a year earlier.
Nine-month results
For the first nine months of 2026, GAAP earnings were $2.710 billion, or $4.13 per diluted share, compared with $1.444 billion, or $2.21, a year earlier. Adjusted earnings were $2.670 billion, or $4.07 per share, against $2.253 billion, or $3.45.
Excluded items in the quarter included a $149 million regulatory disallowance charge at Sempra California and a $97 million gain on the sale of Ecogas, both after tax, with other items also excluded from adjusted results.
Guidance and capital plan
Sempra updated its full-year 2026 GAAP EPS guidance to $7.41 to $8.41. It is guiding to the high end of its 2026 adjusted EPS range of $4.80 to $5.30. The consensus full-year adjusted estimate is $5.13.
Sempra affirmed 2027 EPS guidance of $5.10 to $5.70. It said pending California regulatory outcomes could place it in the lower half of that range unless mitigated. Oncor projects its 2027-2031 base capital plan to rise about 20% from its 2026-2030 plan, and Sempra expects to finalize its 2027-2031 capital plan in February.
The company said the sale of a 45% equity interest in Sempra Infrastructure Partners to affiliates of KKR remains on track to close in the next two weeks.
Shares closed at $82.90 on Wednesday, Nov. 4, the last close before the filing.
Sources
Written with AI from the company's results filing with the SEC, analysts' estimates where we had them, and our market data, and checked against those sources before publishing. Our editorial standards.
More earnings this week
Latest earnings results →- Cummins Misses Revenue Estimates at $9.44 Billion; Lowers Revenue Growth Outlook · CMI · Nov. 5, 2026
- Parker-Hannifin Tops Estimates as Sales Hit Record $6.0 Billion; Adjusted EPS $8.90 · PH · Nov. 5, 2026
- ConocoPhillips Tops EPS Estimates at $3.27 Adjusted as Dividend Rises 11% · COP · Nov. 5, 2026
- Cardinal Health Beats Estimates at $67.5 Billion Revenue, $3.26 Adjusted EPS · CAH · Nov. 5, 2026
More on Sempra
SRE page →Filings, figures and price history are on the Sempra page.